Alpine Bank Wealth Management Astrazeneca PLC Transaction History
Alpine Bank Wealth Management
- $662 Billion
- Q2 2025
A detailed history of Alpine Bank Wealth Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Alpine Bank Wealth Management holds 1,154 shares of AZN stock, worth $86,942. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,154
Previous 986
17.04%
Holding current value
$86,942
Previous $72.5 Million
11.27%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,417Shares Held
510MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.3 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.1 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.68 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.4 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.37 Billion0.39% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...